To test the ability of a daily 3-month treatment with triheptanoin to prevent migraine attacks in 10 migraine patients.
This is an open, non-randomized pilot trial that might justify a placebo-controlled trial, if there are at least 50% of patients with ≥50% reduction in attack frequency.
Age
18–65
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Females aged 18-65 years old having an effective contraception or being menopaused
Diagnosis of migraine without aura (ICHD3beta 1.1) since at least 2 years
4-10 migraine days per month during the last 3 months
No preventive anti-migraine therapy during the last month
You may not be if
\> 4 tension-type headache episodes per month
Medication overuse headache or other headache types
Resistance to \>3 previous preventive anti-migraine drug treatments
